| Company/Division name | Wheeler Bio |
| Parent company | Wheeler Bio |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 20 |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2023 |
| Capital investment ($): | 31 |
| City reshored to: | Oklahoma City |
| State(s) reshored to: | OK |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | antibody contract manufacturer |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Eco-system synergies, Higher productivity |
